乙型肝炎病毒L02细胞转染模型的建立与鉴定
Establishment and identification of L02 cell line transfected by HBV genome
摘要
我们以L02细胞为基础,利用基因重组技术构建含1.3倍加长乙型肝炎病毒(HBV)全基因组的表达质粒pcDNA-HBV,进行基因转染,获得了类似HepG2 2.2.15(简称2.2.15细胞)(HepG2转染HBV DNA后所得)具有复制和分泌HBV能力的HBV转染细胞模型.
出处
《中华肝脏病杂志》
CAS
CSCD
北大核心
2005年第9期702-703,共2页
Chinese Journal of Hepatology
基金
国家自然科学基金(39970858)
参考文献2
-
1吴金明,林菊生,谢娜,姜风超,梁扩寰.β-L-D4A体外抗乙型肝炎病毒作用及其机制[J].中华肝脏病杂志,2003,11(5):268-270. 被引量:7
-
2吴金明,林菊生,陈碧涛,郑新民,赵浩斌,梁扩寰.乙型肝炎病毒基因组转基因小鼠模型的制备与鉴定[J].中华肝脏病杂志,2003,11(6):338-340. 被引量:13
二级参考文献13
-
1Blum HE, Zhang ZS, Galun E, et al. Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol, 1992, 66: 1223-1227.
-
2Ying C, De Clereq E, Neyts J. Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture. J Viral Hepat, 2000, 7: 79-83.
-
3Price PM, Banerjee R, Jeffrey AM, et al. The mechanism of inhibition of hepatitis B virus replication by the carbocyclic analog of 2'-deoxyguanosine. Hepatology, 1992,16: 8-12.
-
4Oberhaus SM, Newbold JE. Detection of DNA polymerase activities associated with purified duck hepatitis B virus core particles by using an activity gel assay. J Virol, 1993, 67: 6558-6566.
-
5Howe AY, Robins MJ, Wilson JS, et al. Selective inhibition of the reverse transcription of duck hepatitis B virus by binding of 2', 3'-dideoxyguanosine 5'-triphosphate to the viral polymerase.Hepatology, 1996, 23: 87-96.
-
6Seeger C, Mason WS. Hepatitis B Virus Biology. Microbiology Mol Biol Rev, 2000, 64: 51-68.
-
7Morrey JD, Bailey KW, Korba BE, et al. Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine. Antiviral. 1999, 42: 97-108.
-
8Junker-Niepmann M, Bartenschlager R, Schaller H. A short cisacting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMEO,1990, 9: 3389-3396.
-
9Guidotti LG, Matzke B, Schaller H, et al. High-level hepatitis B virus replication in transgenic mice. J Virol, 1995, 69: 6158-6169.
-
10Kajino K, K.amiya N, Yuasa S, et aL Evaluation of anti-hepatitis B virus (HBV) drugs using the HBV transgenic mouse. Application of the semiquantitative polymerase chain reaction (PCR) for serum HBV DNA to monitor the drug efficacy. Biochem Biophys Res Commun, 1992, 241: 43-48.
共引文献16
-
1郭晖,陈压西,黄爱龙.Adefovir抗乙型肝炎病毒的体外实验研究[J].重庆医学,2004,33(11):1690-1691.
-
2魏庆信,郑新民,李莉,华文君,魏雁,田永祥,李聚学.小鼠转基因及传代研究[J].实验动物科学与管理,2005,22(1):35-39. 被引量:2
-
3吴金明,林菊生,章金艳,梁扩寰.新的核苷类似物β-L-D4A的细胞内代谢与生物转化[J].中国临床药理学与治疗学,2005,10(6):709-712.
-
4邓家刚,郭宏伟,郝二伟,周程艳.乙型肝炎病毒小鼠动物模型建立的研究现状[J].世界中西医结合杂志,2007,2(3):183-185. 被引量:2
-
5Yan Li Ju-Sheng Lin Ying-Hui Zhang Xiao-Yan Wang Ying Chang Xing-Xing He.Effect and mechanism of β-L-D4A on DNA polymerase α[J].World Journal of Gastroenterology,2007,13(46):6243-6248.
-
6王新,郑佳,周小红,张小霞.嗜酸乳杆菌抑制乙肝病毒E抗原的实验观察[J].天津医药,2008,36(1):44-45.
-
7尤玉琴,黄黎珍,刘光泽,佟明华,李秀梅,胡莲美,顾为望,孔祥平.C基因型HBV转基因小鼠的制备[J].第四军医大学学报,2008,29(6):489-491. 被引量:3
-
8Xing-Xing He Ju-Sheng Lin Ying Chang Ying-Hui Zhang Yan Li Xiao-Yan Wang Dong Xu Xiao-Ming Cheng.Effects of two novel nucleoside analogues on different hepatitis B virus promoters[J].World Journal of Gastroenterology,2008,14(12):1836-1841. 被引量:3
-
9李岩,林菊生,张颖慧,王晓燕,何星星,汪鸿,高玲玲.新型核苷类似物β-L-D4A对人DNA聚合酶β和δ的作用及其机制[J].世界华人消化杂志,2008,16(6):621-628. 被引量:1
-
10李岩,林菊生,张颖慧,王晓燕,何星星.新型抗HBV化合物:-βL-D4A对DNA聚合酶δ的作用及其机制[J].胃肠病学和肝病学杂志,2008,17(4):318-321.
-
1张莉,吴金明,等.乙肝病毒L02细胞转染模型的制备[J].胃肠病学,2002,7(B11):43-43.
-
2和永清.替米沙坦联合氢氯噻嗪治疗老年高血压68例疗效观察[J].北方药学,2013,10(1):27-27. 被引量:3
-
3陈翠卿.拉米夫定与阿德福韦酯治疗HBeAg阳性慢性乙型肝炎的对比分析[J].中国医药科学,2013,3(21):88-89. 被引量:1
-
4刘玲玲,蒋孝华.丙型肝炎病毒体外细胞转染模型的研究进展[J].医学综述,2010,16(19):2905-2907.
-
5杨红玉.瑞舒伐他汀钙治疗老年冠心病合并高脂血症的疗效及安全性[J].中国卫生产业,2012,9(20):70-70. 被引量:5
-
6李永春.他患的是过敏性哮喘吗?[J].中国全科医学,2006,9(20):1724-1724.
-
7张红颖,甄怀蒙.美托洛尔及地高辛对持续性心房颤动心室率控制疗效分析[J].慢性病学杂志,2010,12(9):1012-1012. 被引量:1
-
8向维,丁馨,陈松华,张薛磊.乙型肝炎病毒感染基因转染模型研究进展[J].国际病毒学杂志,2012,19(2):80-83. 被引量:8
-
9谢群香.彩色多普勒超声在胎儿先天性心脏病中的诊断价值[J].当代医学,2015,21(23):78-79. 被引量:16
-
10孔爱菊.尿白蛋白、免疫球蛋白G及β2微球蛋白检测在老年糖尿病患者的临床意义[J].中国实用医刊,2015,42(19):95-96. 被引量:2